Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.

Weller, Johannes; Krzywicka, Katarzyna; van de Munckhof, Anita; Dorn, Franziska; Althaus, Katharina; Bode, Felix J; Bandettini di Poggio, Monica; Buck, Brian; Kleinig, Timothy; Cordonnier, Charlotte; Dizonno, Vanessa; Duan, Jiangang; Elkady, Ahmed; Chew, Beng Lim Alvin; Garcia-Esperon, Carlos; Field, Thalia S; Legault, Catherine; Morin Martin, Mar; Michalski, Dominik; Pelz, Johann; ... (2024). Endovascular treatment of cerebral sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. European stroke journal, 9(1), pp. 105-113. Sage 10.1177/23969873231202363

Text weller-et-al-2023-endovascular-treatment-of-cerebral-sinus-thrombosis-due-to-vaccine-induced-immune-thrombotic.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (623kB)

INTRODUCTION

There is little data on the role of endovascular treatment (EVT) of cerebral venous sinus thrombosis (CVST) due to vaccine-induced immune thrombotic thrombocytopenia (VITT). Here, we describe clinical characteristics and outcomes of CVST-VITT patients who were treated with EVT.

PATIENTS AND METHODS

We report data from an international registry of patients who developed CVST within 28 days of SARS-CoV-2 vaccination, reported between 29 March 2021 and 6 March 2023. VITT was defined according to the Pavord criteria.

RESULTS

EVT was performed in 18/136 (13%) patients with CVST-VITT (92% aspiration and/or stent retrieval, 8% local thrombolysis). Most common indications were extensive thrombosis and clinical or radiological deterioration. Compared to non-EVT patients, those receiving EVT had a higher median thrombus load (4.5 vs 3). Following EVT, local blood flow was improved in 83% (10/12, 95% confidence interval [CI] 54-96). One (6%) asymptomatic sinus perforation occurred. Eight (44%) patients treated with EVT also underwent decompressive surgery. Mortality was 50% (9/18, 95% CI 29-71) and 88% (8/9, 95% CI 25-66) of surviving EVT patients achieved functional independence with a modified Rankin Scale score of 0-2 at follow-up. In multivariable analysis, EVT was not associated with increased mortality (adjusted odds ratio, 0.66, 95% CI 0.16-2.58).

DISCUSSION AND CONCLUSION

We describe the largest cohort of CVST-VITT patients receiving EVT. Half of the patients receiving EVT died during hospital admission, but most survivors achieved functional independence.

Interest & Impact

Downloads

0 since deposited on 03 Oct 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item